866-997-4948(US-Canada Toll Free)

United States Drugs for Malaria Market Report 2022

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

alaria remains one of the most devastating infectious diseases with approximately 212 million infections and 429,000 deaths each year. In 2016, the revenue is 33.8 M USD.

This report studies sales (consumption) of drugs for malaria in USA market, focuses on top players, with revenue, gross margin and market share for each player, covering
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Split by product types, with revenue, market share and growth rate of each type, can be divided into
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Split by applications, this report focuses on revenue, market share and growth rate of drugs for malaria in each application, can be divided into
Prevention
Treatment
Other






Table of Contents

1 Drugs for Malaria Overview1
1.1 Product Overview and Scope of Drugs for Malaria1
1.2 Classification of Drugs for Malaria2
1.2.1 Aryl Aminoalcohol Compounds3
1.2.2 Antifolate Compounds5
1.2.3 Artemisinin Compounds5
1.3 Applications of Drugs for Malaria6
1.3.1 Prevention8
1.3.2 Treatment9
1.4 Overview of Malaria10
1.4.1 Overview Achievements from 2000 to 2015 of Malaria10
1.4.2 Outlook for Progress from 2016 to 2030 of Malaria12
1.5 United States Market Revenue of Drugs for Malaria (2011-2022)15
2 United States Drugs for Malaria Competition by Manufacturers16
2.1 United States Drugs for Malaria Revenue and Share by Manufacturers (2015 and 2016)16
2.2 Drugs for Malaria Market Competitive Situation and Trends19
2.2.1 Drugs for Malaria Market Concentration Rate19
2.2.2 Drugs for Malaria Market Share of Top 3 and Top 5 Manufacturers20
2.2.3 Mergers & Acquisitions, Expansion21
3 United States Drugs for Malaria Revenue (Value) by Types (2011-2016)28
3.1 United States Drugs for Malaria Revenue and Market Share by Types (2011-2016)28
3.2 United States Drugs for Malaria Revenue Growth Rate by Types (2012-2016)35
4 United States Drugs for Malaria Revenue (Value) by Applications (2011-2016)36
4.1 United States Drugs for Malaria Revenue and Market Share by Applications (2011-2016)36
4.2 United States Drugs for Malaria Revenue Growth Rate by Applications (2012-2016)42
4.3 Market Drivers and Opportunities43
5 United States Drugs for Malaria Manufacturers Profiles/Analysis45
5.1 Cipla45
5.1.1 Company Basic Information45
5.1.2 Drugs for Malaria Product Information46
5.1.3 Cipla Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)47
5.1.4 Main Business/Business Overview47
5.2 Guilin Pharmaceutical48
5.2.1 Company Basic Information48
5.2.2 Drugs for Malaria Product Information49
5.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)51
5.2.4 Main Business/Business Overview51
5.3 IPCA Laboratories53
5.3.1 Company Basic Information53
5.3.2 Drugs for Malaria Product Information54
5.3.3 IPCA Laboratories Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)55
5.3.4 Main Business/Business Overview55
5.4 GlaxoSmithKline56
5.4.1 Company Basic Information56
5.4.2 Drugs for Malaria Product Information57
5.4.3 GlaxoSmithKline Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)58
5.4.4 Main Business/Business Overview58
5.5 Mylan Labs59
5.5.1 Company Basic Information59
5.5.2 Drugs for Malaria Product Information60
5.5.3 Mylan Labs Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)60
5.5.4 Main Business/Business Overview61
5.6 Roche61
5.6.1 Company Basic Information61
5.6.2 Drugs for Malaria Product Information62
5.6.3 Roche Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)63
5.6.4 Main Business/Business Overview63
5.7 Novartis65
5.7.1 Company Basic Information65
5.7.2 Drugs for Malaria Product Information66
5.7.3 Novartis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)67
5.7.4 Main Business/Business Overview67
5.8 Sanofi Aventis68
5.8.1 Company Basic Information68
5.8.2 Drugs for Malaria Product Information69
5.8.3 Sanofi Aventis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)70
5.8.4 Main Business/Business Overview71
5.9 Ajanta Pharma71
5.9.1 Company Basic Information71
5.9.2 Drugs for Malaria Product Information72
5.9.3 Ajanta Pharma Drugs for Malaria Revenue, Price and Gross Margin (2012-2017)73
5.9.4 Main Business/Business Overview74
6 Drugs for Malaria Manufacturing Cost Analysis76
6.1 Drugs for Malaria Key Raw Materials Analysis76
6.1.1 Key Raw Materials76
6.1.2 Price Trend of Key Raw Materials78
6.1.3 Key Suppliers of Raw Materials78
6.1.4 Market Concentration Rate of Raw Materials81
6.2 Proportion of Manufacturing Cost Structure81
6.2.1 Raw Materials82
6.2.2 Labor Cost82
6.2.3 Manufacturing Expenses85
6.3 Manufacturing Process Analysis of Drugs for Malaria88
7 Industrial Chain, Sourcing Strategy and Downstream Buyers89
7.1 Drugs for Malaria Industrial Chain Analysis89
7.2 Upstream Raw Materials Sourcing90
7.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 201690
7.4 Downstream Buyers91
8 Marketing Strategy Analysis, Distributors/Traders94
8.1 Marketing Channel94
8.1.1 Direct Marketing94
8.1.2 Indirect Marketing94
8.1.3 Marketing Channel Development Trend95
8.2 Market Positioning95
8.2.1 Pricing Strategy95
8.2.2 Brand Strategy95
8.2.3 Target Client96
8.3 Distributors/Traders List96
9 Market Effect Factors Analysis98
9.1 Technology Progress/Risk98
9.1.1 Substitutes Threat98
9.1.2 Technology Progress in Related Industry98
9.2 Consumer Needs/Customer Preference Change100
9.3 Economic/Political Environmental Change100
10 United States Drugs for Malaria Market Forecast (2017-2022)103
10.1 United States Drugs for Malaria Revenue Forecast (2017-2022)103
10.2 United States Drugs for Malaria Revenue Forecast by Types (2017-2022)103
10.3 United States Drugs for Malaria Revenue Forecast by Application (2017-2022)104
11 Research Findings and Conclusion106
12 Appendix107
Author List107
Key Source of the Report107
Disclosure Section108
Research Methodology108
Data Source110
Disclaimer110

List of Table

List of Tables and Figures

Figure Picture of Drugs for Malaria1
Table Classification of Drugs for Malaria2
Table United States Drugs for Malaria Revenue Share by Types (2015-2016)2
Figure United States Revenue Market Share of Drugs for Malaria by Types in 20163
Figure Aryl Aminoalcohol Compounds Picture4
Figure Antifolate Compounds Picture5
Figure Artemisinin Compounds Picture6
Table Applications of Drugs for Malaria6
Table United States Drugs for Malaria Revenue Market Share by Applications (2015-2016)7
Figure United States Revenue Market Share of Drugs for Malaria by Applications in 20168
Figure Prevention Examples9
Figure Treatment Examples9
Figure Malaria Deaths Averted, 2001-201312
Table Joint Goals, Milestones and Targets for 2016-203014
Figure United States Drugs for Malaria Revenue and Growth Rate (2011-2022)15
Table United States Drugs for Malaria Revenue by Manufacturers (2015 and 2016)16
Table United States Drugs for Malaria Revenue Share by Manufacturers (2015 and 2016)16
Figure 2015 United States Drugs for Malaria Revenue Share by Manufacturers17
Figure 2016 United States Drugs for Malaria Revenue Share by Manufacturers18
Table 2016 United States Drugs for Malaria Revenue Share by Manufacturers19
Figure 2016 Drugs for Malaria Revenue Market Share of Top 3 Manufacturers20
Figure 2016 Drugs for Malaria Revenue Market Share of Top 5 Manufacturers20
Table Mergers & Acquisitions, Expansion21
Table United States Drugs for Malaria Revenue (M USD) by Types (2011-2016)28
Table United States Drugs for Malaria Revenue Share by Types (2011-2016)28
Figure Revenue Market Share of Drugs for Malaria by Types (2011-2016)29
Figure 2011 Revenue Market Share of Drugs for Malaria by Types29
Figure 2012 Revenue Market Share of Drugs for Malaria by Types30
Figure 2013 Revenue Market Share of Drugs for Malaria by Types31
Figure 2014 Revenue Market Share of Drugs for Malaria by Types32
Figure 2015 Revenue Market Share of Drugs for Malaria by Types33
Figure 2016 Revenue Market Share of Drugs for Malaria by Types34
Figure United States Drugs for Malaria Revenue Growth Rate by Types (2012-2016)35
Table United States Drugs for Malaria Revenue by Applications (2011-2016)36
Table United States Drugs for Malaria Revenue Market Share by Applications (2011-2016)36
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201137
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201238
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201339
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201440
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201541
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201642
Table United States Drugs for Malaria Revenue Growth Rate by Applications (2012-2016)42
Figure United States Drugs for Malaria Revenue Growth Rate by Applications (2012-2016)43
Table Market Drivers43
Table Cipla Basic Information List45
Figure Drugs for Malaria Product Information46
Table Cipla Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)47
Table Guilin Pharmaceutical Basic Information List48
Table Drugs for Malaria Product Information49
Table Guilin Pharmaceutical Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)51
Table IPCA Laboratories Basic Information List53
Figure Drugs for Malaria Product Information54
Table IPCA Laboratories Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)55
Table GlaxoSmithKline Basic Information List56
Table Drugs for Malaria Product Information57
Table GlaxoSmithKline Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)58
Table Mylan Labs Basic Information List59
Table Drugs for Malaria Product Information60
Table Mylan Labs Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)60
Table Roche Basic Information List61
Table Drugs for Malaria Product Information62
Table Roche Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)63
Table Novartis Basic Information List65
Table Drugs for Malaria Product Information66
Table Novartis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)67
Table Sanofi Aventis Basic Information List68
Table Drugs for Malaria Product Information69
Table Sanofi Aventis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)70
Table Ajanta Pharma Basic Information List71
Table Drugs for Malaria Product Information72
Table Ajanta Pharma Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)73
Table Picture of Raw Materials76
Figure Price Trend of Artemisinin 2013-201678
Table Key Suppliers of Raw Materials78
Figure Market Concentration Rate of Artemisinin81
Figure Manufacturing Cost Structure of Drugs for Malaria81
Figure United States Overview of Average Hourly Wages 2015-2016 (USD/Hour)82
Figure United States Overview of Labor Costs 2013-2016 (110 Index Points)83
Figure Cost of Employing a Factory Worker85
Table Average Price of Electricity to Ultimate Customers86
Figure Manufacturing Process Analysis of Drugs for Malaria88
Figure Drugs for Malaria Industrial Chain Analysis89
Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 201690
Table Major Buyers of Drugs for Malaria91
Table Distributors/Traders List96
Figure Global GDP Growth Rate for 2015101
Figure United States GDP 2006-2016 (Billion USD)102
Figure United States CPI Change 2016-2017102
Figure United States Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)103
Table United States Drugs for Malaria Revenue Forecast by Types (2017-2022)103
Table United States Drugs for Malaria Revenue Share Forecast by Types (2017-2022)104
Table United States Drugs for Malaria Revenue Forecast by Application (2017-2022)104
Table United States Drugs for Malaria Revenue Share Forecast by Application (2017-2022)105

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *